The overall goal of the UT Houston Substance Abuse Research-Medication Development Center (SARMDC) is to develop safe and effective medications for cocaine dependence through the study of the behavioral and neurochemical mechanisms associated with the promising initial findings of replacement therapy. The Administrative Core will promote this goal by serving as a general resource for other projects and the Advanced Clinical Design &Statistical Methodology Core.
The Specific Aims of the Administrative core are listed below:
Aim 1. To provide infrastructure support for clinical trials issues, including: a) subject recruitment and screening b) urine toxicology testing, c) ensuring subject confidentiality and compliance with IRB and HIPPA requirements and regulations d) documenting clinical trials on e) oversight of data sharing with NIDA.
Aim 2. To provide support for Training and Education, including recruitment, supervision, and evaluation of trainees affiliated with the center.
Aim 3. To provide Fiscal and Management support, including support for pilot studies, budgetary oversight, and management of research staff.
Aim 4. To serve as the Liaison between the center and outside entities including the Department of Psychiatry, the UT Health Sciences Center, the Center for Clinical Translational Science of the University of Texas Health Science Center at Houston, the scientific advisory board, collaborating entities including addiction researchers at Baylor College of Medicine and University of Texas Medical Branch (UTMB) in Galveston, as well as NIDA.

Public Health Relevance

The administrative core of the UT Houston Substance Abuse Research-Medication Development Center (SAR-MDC) will promote the goal of the center, to gain a greater understanding of the basic neurobiology of cocaine dependence in order to develop safe and effective treatments of the disorder, by providing infrastructure for clinical trials, training and education, and fiscal managerial support for the projects of the center

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZDA1-EXL-T)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Health Science Center Houston
United States
Zip Code
Lindsay, Jan A; Minard, Charles G; Hudson, Sonora et al. (2014) Using prize-based incentives to enhance daily interactive voice response (IVR) compliance: a feasibility study. J Subst Abuse Treat 46:74-7
Sharma, Jyoti; Rathnayaka, Nuvan; Green, Charles et al. (2014) Bradycardia as a Marker of Chronic Cocaine Use: A Novel Cardiovascular Finding. Behav Med :1-8
Schmitz, Joy M; Green, Charles E; Stotts, Angela L et al. (2014) A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone. Drug Alcohol Depend 136:100-7
Narayana, Ponnada A; Herrera, Juan J; Bockhorst, Kurt H et al. (2014) Chronic cocaine administration causes extensive white matter damage in brain: diffusion tensor imaging and immunohistochemistry studies. Psychiatry Res 221:220-30
Farris, Samantha G; Zvolensky, Michael J; Beckham, Jean C et al. (2014) Trauma exposure and cigarette smoking: the impact of negative affect and affect-regulatory smoking motives. J Addict Dis 33:354-65
Hasan, Khader M; Moeller, F Gerard; Narayana, Ponnada A (2014) DTI-based segmentation and quantification of human brain lateral ventricular CSF volumetry and mean diffusivity: validation, age, gender effects and biophysical implications. Magn Reson Imaging 32:405-12
Fineberg, Naomi A; Chamberlain, Samuel R; Goudriaan, Anna E et al. (2014) New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity. CNS Spectr 19:69-89
Lane, Scott D; Green, Charles E; Schmitz, Joy M et al. (2014) Comparison of Caffeine and d-amphetamine in Cocaine-Dependent Subjects: Differential Outcomes on Subjective and Cardiovascular Effects, Reward Learning, and Salivary Paraxanthine. J Addict Res Ther 5:176
Liu, Shijing; Green, Charles E; Lane, Scott D et al. (2014) The influence of dopamine ?-hydroxylase gene polymorphism rs1611115 on levodopa/carbidopa treatment for cocaine dependence: a preliminary study. Pharmacogenet Genomics 24:370-3
Anastasio, N C; Liu, S; Maili, L et al. (2014) Variation within the serotonin (5-HT) 5-HT?C receptor system aligns with vulnerability to cocaine cue reactivity. Transl Psychiatry 4:e369

Showing the most recent 10 out of 55 publications